Advertisement

Topics

Alexion Pharmaceuticals Incorporated Company Profile

18:46 EST 12th December 2018 | BioPortfolio

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rare diseases. Alexion scientists are among the first in the world to unlock the therapeutic potential of inhibiting terminal complement, a group of proteins that play an important role in the body's immune response and can destroy healthy tissue in certain patients.

Alexion discovered and developed Soliris® (eculizumab), a first-in-class terminal complement inhibitor approved in the United States, European Union, Canada and Australia as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH). Alexion is working urgently to investigate Soliris and additional biopharmaceuticals as treatments for patients with other rare and severe diseases, including cancer.

Location

352 Knotter Drive
Cheshire
06410
United States of America

Contact

Phone: 203 272 2596
Fax: 203 772 3655
Email: alexion.europe@alxn.com


News Articles [443 Associated News Articles listed on BioPortfolio]

Alexion Pharmaceuticals Turns Lower Despite Upbeat Q3 Earnings, Guidance

WASHINGTON (dpa-AFX) - After seeing initial strength, shares of Alexion Pharmaceuticals (ALXN) have moved sharply lower over the course of the trading session on Wednesday. Alexion is currently do...

Deals and M&As this week: Alexion Pharmaceuticals, Recipharm, AstraZeneca

Alexion Pharmaceuticals has partnered with Complement Pharma for the co-development of pre-clinical complement inhibitor for neurodegenerative disorders. The two companies will...Read More... The pos...

M&As this week: Alexion Pharmaceutical, OvaScience

Alexion Pharmaceuticals has completed an acquisition of Syntimmune. Following the transaction, Syntimmune will add its clinical-stage drug candidate SYNT001 to Alexion’s...Read More... The post...

Alexion to Obtain Syntimmune for $400M up Front

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune have just today announced that Alexion will be acquiring Syntimmune, a company working to produce antibody therapeutics that focus on the neo...

Syntimmune Turns Drug For Rare Anemia Into $400M Alexion Buyout

Syntimmune, a biotech startup formed by the veteran founders of the hemophilia drug developer Syntonix, has been acquired by Alexion Pharmaceuticals for $400 million in cash up front. Syntimmune is ri...

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryAlexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a...

Alexion Pharmaceuticals: TSI-Aufsteiger der Woche

Kulmbach (www.aktiencheck.de) - Alexion Pharmaceuticals-Aktienanalyse des Online-Anlegermagazins "Der Aktionär": "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des US-Biotechkonzer....

Alexion’s Soliris successor in PNH unlikely to achieve price premium

Alexion Pharmaceuticals’ ALXN1210 for paroxysmal nocturnal hemoglobinuria (PNH) is unlikely to see a price premium to Alexion’s Soliris (eculizumab) once approved. However, a slight...Read Mor...

PubMed Articles [130 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1378 Associated Companies listed on BioPortfolio]

Alexion Antibody Technologies, Inc.

Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a portfolio of antibody therapeutics targeting se...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Alexion Pharmaceuticals, Inc. and Dicerna Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:

More Information about "Alexion Pharmaceuticals Incorporated" on BioPortfolio

We have published hundreds of Alexion Pharmaceuticals Incorporated news stories on BioPortfolio along with dozens of Alexion Pharmaceuticals Incorporated Clinical Trials and PubMed Articles about Alexion Pharmaceuticals Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alexion Pharmaceuticals Incorporated Companies in our database. You can also find out about relevant Alexion Pharmaceuticals Incorporated Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record